Wexford Capital’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-6,500
| Closed | -$617K | – | 269 |
|
|
2024
Q1 | $617K | Buy |
+6,500
| New | +$617K | 0.13% | 113 |
|
|
2018
Q4 | – | Sell |
-35,266
| Closed | -$3.38M | – | 156 |
|
|
2018
Q3 | $3.38M | Buy |
+35,266
| New | +$3.38M | 0.22% | 52 |
|
|
2017
Q4 | – | Sell |
-113,230
| Closed | -$9.8M | – | 169 |
|
|
2017
Q3 | $9.8M | Buy |
+113,230
| New | +$9.8M | 0.84% | 26 |
|
|
2016
Q4 | – | Sell |
-82,180
| Closed | -$5.45M | – | 313 |
|
|
2016
Q3 | $5.45M | Buy |
+82,180
| New | +$5.45M | 0.89% | 33 |
|